DEMANT AS A DK 0,2/ DK0060738599 /
24.06.2024 9:06:02 | Изменение -0.020 | Объем сделки | Бид9:36:36 | Предложение9:36:36 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
40.800EUR | -0.05% | 0 Оборот: 0.000 |
40.980Величина цены спроса: 700 | 41.560Величина цены предложения: 700 | 9.07 млрдEUR | - | - |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница